BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26227398)

  • 1. Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.
    Li JE; Futawaka K; Yamamoto H; Kasahara M; Tagami T; Liu TH; Moriyama K
    Am J Chin Med; 2015; 43(5):879-92. PubMed ID: 26227398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.
    Shrivastav S; Kino T; Cunningham T; Ichijo T; Schubert U; Heinklein P; Chrousos GP; Kopp JB
    Mol Endocrinol; 2008 Feb; 22(2):234-47. PubMed ID: 17932108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contrasting roles of PPARδ and PPARγ in regulating the metabolic switch between oxidation and storage of fats in white adipose tissue.
    Roberts LD; Murray AJ; Menassa D; Ashmore T; Nicholls AW; Griffin JL
    Genome Biol; 2011 Aug; 12(8):R75. PubMed ID: 21843327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.
    Hamza MS; Pott S; Vega VB; Thomsen JS; Kandhadayar GS; Ng PW; Chiu KP; Pettersson S; Wei CL; Ruan Y; Liu ET
    PLoS One; 2009; 4(3):e4907. PubMed ID: 19300518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction.
    Ravnskjaer K; Frigerio F; Boergesen M; Nielsen T; Maechler P; Mandrup S
    J Lipid Res; 2010 Jun; 51(6):1370-9. PubMed ID: 19965574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes.
    Robciuc MR; Skrobuk P; Anisimov A; Olkkonen VM; Alitalo K; Eckel RH; Koistinen HA; Jauhiainen M; Ehnholm C
    PLoS One; 2012; 7(10):e46212. PubMed ID: 23056264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of HOX gene expression and regulation in adipocyte development.
    Kumar V; Sekar M; Sarkar P; Acharya KK; Thirumurugan K
    Gene; 2021 Feb; 768():145308. PubMed ID: 33197517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of arachidonic acid metabolites on PPAR and RXR expression in bovine uterine cells.
    Szczepańska AA; Łupicka M; Socha BM; Korzekwa AJ
    Gen Comp Endocrinol; 2018 Jun; 262():27-35. PubMed ID: 29510153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of porcine peroxisome proliferator-activated receptor delta regulates adipogenesis in mouse myoblasts.
    Yu YH; Wu SC; Cheng WT; Mersmann HJ; Ding ST
    J Anim Sci; 2008 Jan; 86(1):64-72. PubMed ID: 17878286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
    Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
    Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids.
    de Lange P; Feola A; Ragni M; Senese R; Moreno M; Lombardi A; Silvestri E; Amat R; Villarroya F; Goglia F; Lanni A
    Endocrinology; 2007 Aug; 148(8):4064-72. PubMed ID: 17478558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholines activate PPARδ and protect human skeletal muscle cells from lipotoxicity.
    Klingler C; Zhao X; Adhikary T; Li J; Xu G; Häring HU; Schleicher E; Lehmann R; Weigert C
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1980-1992. PubMed ID: 27697477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects.
    Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY
    Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
    Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
    Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.